HAVCR1 and Stroke: L-NAME/ANG II significantly increased systolic blood pressure, aldosterone, cardiac injury/stroke composite score, albuminuria and renal proximal tubular damage characterized by increased renal KIM-1 immunostaining, urinary KIM-1 and renal KIM-1 mRNA expression.